✦ LIBER ✦

DOUBLE-BLIND, CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN TREATMENT OF MULTIPLE SCLEROSIS

✍ Scribed by Thompson, EdwardJ.; Healy, MichaelJ.R.; Mertin, Jürgen; Knight, StellaC.; Rudge, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DOUBLE-BLIND CONTROLLED TRIAL OF IMMUNOS

✍ Mertin, J.; Kremer, M.; Knight, S.C.; Batchelor, J.R.; Halliday, A.M.; Rudge, P. 📂 Article 📅 1982 🏛 The Lancet 🌐 English ⚖ 562 KB

Multicenter double-blind controlled tria

✍ Koetsier, J.C.; van Walbeek, H.; Mispelblom Beijer, J.; Rudge, P. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Treatment of multiple sclerosis with non

✍ E. Roullet; P. Cesaro; J. Choay; N. Simon-Lavoine; J-D. Degos; R. Marteau 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Ketanserin in the treatment of systemic

✍ J.P. ORTONNE; C. TORZUOLI; P. DUJARDIN; B. FRAITAG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Intravenous immunoglobulin treatment in

✍ A. Achiron; R. Gilad; S. Hassin; Y. Barak; U. Gabbay; I. Ziv; Y. Goldhamer; E. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Sustained-release oral fampridine in mul

✍ Andrew D Goodman; Theodore R Brown; Lauren B Krupp; Randall T Schapiro; Steven R 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 166 KB